ATE222771T1 - Zusammensetzung und verfahren zur vermeidung von infektionen durch respiratorische viren - Google Patents

Zusammensetzung und verfahren zur vermeidung von infektionen durch respiratorische viren

Info

Publication number
ATE222771T1
ATE222771T1 AT96904605T AT96904605T ATE222771T1 AT E222771 T1 ATE222771 T1 AT E222771T1 AT 96904605 T AT96904605 T AT 96904605T AT 96904605 T AT96904605 T AT 96904605T AT E222771 T1 ATE222771 T1 AT E222771T1
Authority
AT
Austria
Prior art keywords
composition
infections caused
respiratory viruses
preventing infections
virus
Prior art date
Application number
AT96904605T
Other languages
English (en)
Inventor
Milo Duane Hilty
Steven Neal Anderson
Joseph Paul Schaller
Jin-Zhou Liu
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23526176&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE222771(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE222771T1 publication Critical patent/ATE222771T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Physical Water Treatments (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Water Treatment By Sorption (AREA)
AT96904605T 1995-02-10 1996-02-08 Zusammensetzung und verfahren zur vermeidung von infektionen durch respiratorische viren ATE222771T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/386,576 US5922344A (en) 1995-02-10 1995-02-10 Product for prevention of respiratory virus infection and method of use
PCT/US1996/001790 WO1996031186A2 (en) 1995-02-10 1996-02-08 Product and method for preventing respiratory virus infection

Publications (1)

Publication Number Publication Date
ATE222771T1 true ATE222771T1 (de) 2002-09-15

Family

ID=23526176

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96904605T ATE222771T1 (de) 1995-02-10 1996-02-08 Zusammensetzung und verfahren zur vermeidung von infektionen durch respiratorische viren

Country Status (11)

Country Link
US (1) US5922344A (de)
EP (1) EP0808173B1 (de)
JP (1) JP2002517167A (de)
AT (1) ATE222771T1 (de)
AU (1) AU4866696A (de)
CA (1) CA2212562A1 (de)
DE (1) DE69623261T2 (de)
DK (1) DK0808173T3 (de)
ES (1) ES2184853T3 (de)
PT (1) PT808173E (de)
WO (1) WO1996031186A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9701026D0 (sv) * 1997-03-20 1997-03-20 Immun System Ims Ab use of avian antibodies
DE602004006258T3 (de) * 2004-08-24 2013-08-29 Nutricia N.V. Nahrungszusammensetzung die unverdauliche Transgalaktooligosaccharide sowie verdauliche Galaktose-Saccharide enthält
JP2009528828A (ja) * 2006-03-06 2009-08-13 シムフォゲン・アクティーゼルスカブ 消化器多核体ウイルス感染症の治療のための組み換えポリクローナル抗体
KR101423586B1 (ko) * 2006-08-25 2014-07-25 폴 코포레이션 정화 요소를 포함하는 유체 조립체
CA2678628A1 (en) * 2007-03-06 2008-09-12 Symphogen A/S Recombinant antibodies for treatment of respiratory syncytial virus infections
BRPI0817257A2 (pt) * 2007-09-24 2015-06-16 Univ Vanderbilt Anticorpos moniclonais para vírus sincital respiratório e usos dos mesmos
US20230397620A1 (en) * 2022-06-08 2023-12-14 Bby, Inc. Powderization of Human Milk

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3911108A (en) * 1973-02-14 1975-10-07 Diamond Shamrock Corp Process of producing bovine milk products containing specific antibodies
US5066491A (en) * 1985-04-15 1991-11-19 Protein Technology, Inc. Method of disease treatment utilizing an immunologically active whey fraction
US4800078A (en) * 1987-05-28 1989-01-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Immunotherapeutic method of treating respiratory disease by intranasal administration of Igb
CA2040770A1 (en) * 1990-04-19 1991-10-20 James F. Young Administration of monoclonal antibodies against respiratory viruses
AU644210B2 (en) * 1990-07-19 1993-12-02 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Improved immunotherapeutic method of preventing or treating viral respiratory tract disease
WO1992019244A2 (en) * 1991-05-01 1992-11-12 Henry M. Jackson Foundation For The Advancement Of Military Medicine A method for treating infectious respiratory diseases
WO1994017105A1 (en) * 1993-01-29 1994-08-04 Medimmune, Inc. Human-murine chimeric antibodies against respiratory syncytial virus
JPH06345668A (ja) * 1993-06-07 1994-12-20 Shibayagi:Kk 感染防御組成物およびその用途

Also Published As

Publication number Publication date
DK0808173T3 (da) 2002-11-04
JP2002517167A (ja) 2002-06-11
AU4866696A (en) 1996-10-23
US5922344A (en) 1999-07-13
PT808173E (pt) 2003-01-31
WO1996031186A2 (en) 1996-10-10
MX9706098A (es) 1997-10-31
CA2212562A1 (en) 1996-10-10
ES2184853T3 (es) 2003-04-16
EP0808173A2 (de) 1997-11-26
WO1996031186A3 (en) 1996-11-14
EP0808173B1 (de) 2002-08-28
DE69623261T2 (de) 2003-04-17
DE69623261D1 (de) 2002-10-02

Similar Documents

Publication Publication Date Title
DE69818707D1 (de) Chitosan und influenza-antigen(e) enthaltende impfstoff-zubereitungen zur verabreichung durch eine mukosa
BR9814375A (pt) Inibição de raf cinase usando difenil uréias substituìdas simétricas e assimétricas
TW200501985A (en) Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodies
ID27787A (id) Senyawa, komposisi dan metode untuk pengobatan atau pencegahan infeksi yang disebabkan oleh virus dan penyakit-penyakit yang berkaitan
BR9711095A (pt) Composto de ciclopentano substituìdo, composição e método para inibir neuraminidase de vìrus influenza e método para tratar infecção de vìrus influenza
ES2081716T3 (es) Procedimiento para la fabricacion de resina de organopolisiloxano.
CY1110873T1 (el) Σταθεροποιημενα σκευασματα αντισωματων anti-rsv, υγρης μορφης
ATE476983T1 (de) Immunostimulierende polynukleotide sequenzen zur verwendung bei der verhinderung und behandlung von viralen erkrankungen der atemwege
ATE427129T1 (de) Abgabevorrichtung fur arzneimittel
BR0111569A (pt) Agentes antivirais de imidazopiridina e imidazopirimidina
BR0209271A (pt) Composto, uso de um composto composição farmacêutica, formulação em aerossol farmacêutica, método para o tratamento de um paciente humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para a preparação de um composto
BR0013771A (pt) Composto, métodos de tratamento de uma infecção viral em um mamìfero, de inibir a transcriptase reversa do hiv, e de prevenção da infecção do hiv ou de tratar a infecção do hiv, uso de um composto, e, composição farmacêutica
EP0652011A4 (de) Prophylaktisches mittel und arzneimittel für virale erkrankungen der atemwege.
ATE235506T1 (de) Behandlung einer proteinlösung mit a1/fe und anschliesende membrankonzentration
OA08652A (fr) Compositions, vaccin et anticorps monoclonaux utiles pour le traitement des affections par le virus HIV et procédés de production de ces anticorps et de diagnostic de la présence de ce virus.
ATE222771T1 (de) Zusammensetzung und verfahren zur vermeidung von infektionen durch respiratorische viren
ATE429248T1 (de) Verwendung cd28 spezifischer monoklonaler antikörper zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von virusinfektionen
BRPI0512951A (pt) compostos, processo para sua fabricação, composições farmacêuticas contendo os mesmos, uso e método para tratamento e/ou prevenção de doenças que são moduladas pelos agonistas de ppar(delta) e/ou ppar(alpha)
NZ505894A (en) Methylenebisbenzaldehyde derivatives, methylidynetrisphenol derivative and pharmaceuticals thereof; useful for treating or preventing pneumovirus infection and associated diseases
ATE172198T1 (de) Verfahren zur herstellung von n-acetyl- neuraminsäurederivaten
DE69230790D1 (de) Arzneimittel zur Behandlung von durch Babesia verursachten Protozoeninfektionen
BR9814933A (pt) Composto, composicao farmaceutica e metodo de tratamento de infeccao por hiv.
BR9808392A (pt) Uso de anticorpos de aves, e, processo para tratar infecções do trato respiratório.
KR970701561A (ko) 신규 기도부 바이러스 질환 치료제(Novel Remedy for Respiratory-Tract Viral Disease)
NO963143D0 (no) Oral legemiddelform inneholdende colestipol som bærer med sure virkestoffer og fremgangsmåte ved fremstilling av denne

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0808173

Country of ref document: EP

REN Ceased due to non-payment of the annual fee
RZN Patent revoked